Shlomo Ben‐Efraim - Concepedia

Author

Shlomo Ben‐Efraim

Also Known As

S BEN-EFRAIM, S BENEFRAIM, S Ben-Efraim, S. BEN-EFRAIM, S. BEN‐EFRAIM, S. Ben-Efraim, S. Ben‐Efraim, SHLOMO BEN-EFRAIM, Shlomo Ben-Efraim, Shlomo Benefraim

187

Publications

2.4K

Citations

H-Index

110

Concepts

All Affiliations

Tel Aviv University Erasmus University Rotterdam Weizmann Institute of Science Meir Medical Center Israel Institute for Biological Research

About

Shlomo Ben‐Efraim is an author at Tel Aviv University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	37	1K
2	Allergy	12	13	318
3	Health Sciences	4	4	170
4	Allergy Medicine	2	2	48
5	Biochemistry	1	1	20

Shlomo Ben‐Efraim

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity of a Series of α,N-DNP-L-Lysines<sup>*</sup> Stuart F. Schlossman, Arieh Yaron, Shlomo Ben‐Efraim, Biochemistry ImmunotoxicologyImmunologyAltmetric Attention ScoreImmunodominanceAntigen Processing	1965	103
Effect of endothelin-1 on α-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung diseases Iris Shahar, Elizabeth Fireman, M Topilsky, International Journal of Immunopharmacology InflammationFibrosisPulmonary CirculationInflammatory Lung DiseaseLung Inflammation	1999	85
IMMUNOCHEMICAL STUDIES ON THE ANTIGENIC DETERMINANTS REQUIRED TO ELICIT DELAYED AND IMMEDIATE HYPERSENSITIVITY REACTIONS Stuart F. Schlossman, Shlomo Ben‐Efraim, Arieh Yaron, The Journal of Experimental Medicine ImmunologyImmune RegulationImmunodominanceSkin AllergyPeptide Science	1966	71
NEW ANTIGENIC COMPONENT OF<i>PASTEURELLA PESTIS</i>FORMED UNDER SPECIFIED CONDITIONS OF pH AND TEMPERATURE Shlomo Ben‐Efraim, Moshe Aronson, Leah Bichowsky-Slomnicki Journal of Bacteriology HyperparasiteMicrobiologyInsect VirusNew Antigenic Component	1961	58
Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth Shlomo Ben‐Efraim, Robert C. Bocian, Margalit B. Mokyr, Cancer Immunology Immunotherapy Melphalan TherapyMedicineMalignant Blood DisorderPathologyImmune Checkpoint Inhibitor	1983	58
Prostaglandin E2 inhibits the release of tumor necrosis factor-α, rather than interleukin 1β, from human macrophages M. W. J. A. Fieren, Gert-Jan C.M. van den Bemd, Shlomo Ben‐Efraim, Immunology Letters InflammationCytokineProstaglandin E2Anti-inflammatoryHuman Macrophages	1992	52
Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock T Mózes, Shlomo Ben‐Efraim, CornéJ.A.M. Tak, Immunology Letters InflammationTumor Necrosis FactorPathologySepsisCell Death	1991	47
Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs; protective effects of indomethacin T Mózes, Freek J. Zijlstra, Jan P.C. Heiligers, British Journal of Pharmacology	1991	43
Immunocompetence, immunosuppression, and human breast cancer. III. Prognostic significance of initial level of immunocompetence in early and advanced disease Aliza Adler, Joseph Allen Stein, Shlomo Ben‐Efraim Cancer Surgical OncologyBreast OncologyStage IiCancer ImmunosurveillanceMedicine	1980	38
BIOLOGICAL ACTIVITIES IN EXTRACTS OF <i>PASTEURELLA PESTIS</i> AND THEIR RELATION TO THE “pH 6 ANTIGEN” Leah Bichowsky-Slomnicki, Shlomo Ben‐Efraim Journal of Bacteriology	1963	35

Page 1